Literature DB >> 32435334

Intensity and Distribution of Patchy Late Gadolinium Enhancement in Left Atrium in Patients With Atrial Fibrillation.

Olga P Aparina1, Olga V Stukalova2, Nataliia A Mironova1, Denis V Parkhomenko3, Sergey K Ternovoy2,4, Sergey P Golitsyn1.   

Abstract

PURPOSE: Late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (MRI) studies were performed on healthy individuals to establish signal intensity thresholds for reproducible left atrial (LA) patchy LGE detection. Using established criteria, differences in LA patchy LGE between healthy volunteers (HV) and patients with atrial fibrillation (AF) or hypertension were analyzed.
METHODS: Fifty-three patents with AF (mean age 56 years, 60% men), 25 patients with hypertension and no history of AF (mean age 54 years, 40% men), and 28 HV (mean age 50 years, 52% men) were enrolled in an observational, non-interventional, case-control prospective study. LA patchy LGE quantification was performed using LGE MRI (1.5 T scanner, voxel size 1.25x1.25x2.5 mm) and the custom-built software based on estimation of LA voxel image intensity ratio and comparison with threshold value obtained from HV data.
RESULTS: Based on analysis of healthy individuals' data, the optimal threshold value for the left atrial patchy LGE quantification was determined at 1.38. Patients with AF had a higher extent of LA patchy LGE (9.1 [1.72; 18.58] %) than patients with hypertension (3.81 [0.57; 9.51] %) and HV (0.78 [0.05; 3.5] %). The predominant location of LA patchy LGE in AF was in the pulmonary vein ostia region, in hypertension - LA posterior wall, and in HV - lower part of LA posterior wall. In AF patients, the extent of LA patchy LGE correlated with LA end-diastolic volume (r=0.37) and LA ejection fraction (r=-0.4), in HV - with age (r=0.66) and LA end-diastolic volume (r=0.4).
CONCLUSION: AF and hypertension are associated with higher extent and different location of LA patchy LGE compared to changes caused by natural aging. The extent of LA patchy enhancement correlates with LA dilatation.

Entities:  

Keywords:  Aging; Atrial fibrillation; Hypertension; Late gadolinium magnetic resonance imaging; Left atrium; Structural remodeling

Year:  2019        PMID: 32435334      PMCID: PMC7237097          DOI: 10.4022/jafib.2206

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  27 in total

1.  Evaluation of quantification methods for left arial late gadolinium enhancement based on different references in patients with atrial fibrillation.

Authors:  Sung Ho Hwang; Yu-Whan Oh; Dae In Lee; Jaemin Shim; Sang-Weon Park; Young-Hoon Kim
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-04       Impact factor: 2.357

2.  Massive calcification of the mitral annulus. A clinicopathological study of fourteen cases.

Authors:  D KORN; R W DESANCTIS; S SELL
Journal:  N Engl J Med       Date:  1962-11-01       Impact factor: 91.245

3.  Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population.

Authors:  Hubert Cochet; Amaury Mouries; Hubert Nivet; Frederic Sacher; Nicolas Derval; Arnaud Denis; Mathilde Merle; Jatin Relan; Mélèze Hocini; Michel Haïssaguerre; François Laurent; Michel Montaudon; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-22

4.  Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.

Authors:  Mohammadali Habibi; Joao A C Lima; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; Kotaro Fukumoto; David Spragg; Hiroshi Ashikaga; John Rickard; Joseph E Marine; Hugh Calkins; Saman Nazarian
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

Review 5.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

Authors:  Jocasta Ball; Melinda J Carrington; John J V McMurray; Simon Stewart
Journal:  Int J Cardiol       Date:  2013-02-04       Impact factor: 4.164

6.  Left atrial aging: a cardiac magnetic resonance feature-tracking study.

Authors:  Morgane Evin; Alban Redheuil; Gilles Soulat; Ludivine Perdrix; Golmehr Ashrafpoor; Alain Giron; Jérôme Lamy; Carine Defrance; Charles Roux; Stéphane N Hatem; Benoit Diebold; Elie Mousseaux; Nadjia Kachenoura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-08       Impact factor: 4.733

7.  Electrophysiologic and electroanatomic changes in the human atrium associated with age.

Authors:  Peter M Kistler; Prashanthan Sanders; Simon P Fynn; Irene H Stevenson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

Review 8.  Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy.

Authors:  Hans Kottkamp
Journal:  Eur Heart J       Date:  2013-06-11       Impact factor: 29.983

9.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

10.  Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility.

Authors:  Eva M Benito; Alicia Carlosena-Remirez; Eduard Guasch; Susana Prat-González; Rosario J Perea; Rosa Figueras; Roger Borràs; David Andreu; Elena Arbelo; J Maria Tolosana; Felipe Bisbal; Josep Brugada; Antonio Berruezo; Lluis Mont
Journal:  Europace       Date:  2017-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.